BioSpace News Archive

Conference Call Today at 4:30 p.m. ET

Puma Biotechnology, Inc. announced financial results for the second quarter ended June 30, 2018.

Cigna Corporation issued the following letter to stockholders in response to the second letter released by Carl C. Icahn about the Company’s proposed merger with Express Scripts Holding Company

ARCA biopharma, Inc. reported financial results for the quarter ended June 30, 2018.

Kadmon Holdings, Inc. provided a business update and reported financial and operational results for the second quarter of 2018.

BioCardia®, Inc. reported financial results and business highlights for the second quarter 2018 and filed its quarterly report on Form 10-Q for the three and six months ended June 30, 2018 with the Securities and Exchange Commission.

The Board of Directors of AmerisourceBergen Corporation declared a quarterly dividend of $0.38 per common share, payable September 4, 2018, to stockholders of record at the close of business on August 20, 2018.

Elite Pharmaceuticals, Inc. announced results for the first quarter of fiscal year 2019 ended June 30, 2018 (“First Quarter”).

New $17 million acquisition and operating banking facility with major international bank HSBC and Export Development Canada.

i2 Pharmaceuticals, Inc.a biopharmaceutical company focused on next generation discovery and development of therapeutics with a focus on personalized cancer treatment, announced the appointment of David Stover, Ph.D., as Chief Executive Officer, effective July 1, 2018. Dr. Stover brings to i2 over 25 years of experience in both small-molecule and biologics drug discovery and development.